HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imaging appearance of dextranomer/hyaluronic acid copolymer implant injections for treatment of velopharyngeal insufficiency.

AbstractBACKGROUND AND PURPOSE:
Dextranomer/hyaluronic acid copolymer implants are used in treating velopharyngeal insufficiency. These posterior nasopharyngeal implants can be mistaken for pathologic conditions such as retropharyngeal abscess on imaging. We studied the imaging appearance of dextranomer/hyaluronic acid copolymer implants in patients treated for velopharyngeal insufficiency.
MATERIALS AND METHODS:
A consecutive series of patients with velopharyngeal insufficiency treated with dextranomer/hyaluronic acid copolymer were included in this study. Data on patient characteristics and volume of dextranomer/hyaluronic acid copolymer injected were obtained. Postoperative imaging characteristics on plain radiography, CT, and MR imaging were assessed. The imaging appearance of postoperative complications was determined.
RESULTS:
Sixteen patients were included in this study. Seven patients underwent postoperative plain radiographs, 5 patients underwent CT, and 9 patients underwent MR imaging. Plain radiographs demonstrated soft-tissue swelling in the retropharyngeal space, which resolved at 1 month. On CT, dextranomer/hyaluronic acid copolymer implants appeared as bilateral nasopharyngeal soft-tissue masses isoattenuated to hypoattenuated relative to muscle in 80% (4/5) of patients. On MR imaging, dextranomer/hyaluronic acid copolymer implants appeared as bilateral nasopharyngeal soft-tissue masses that were isointense to muscle on T1 (8/9, 88.9%) and hyperintense to muscle on T2 (8/9, 88.9%) and demonstrated no restricted diffusion (4/4, 100.0%) or peripheral enhancement (7/7, 100.0%).
CONCLUSIONS:
The normal postoperative findings of posterior nasopharyngeal dextranomer/hyaluronic acid copolymer injection on MR imaging is characterized by the presence of bilateral nasopharyngeal soft-tissue masses that are isointense to muscle on T1 and hyperintense on T2, with no restricted diffusion or peripheral enhancement. Velopharyngeal dextranomer/hyaluronic acid copolymer implants are iso- to hypoattenuated to muscle on CT and are not visible radiographically once associated implantation-related swelling has resolved.
AuthorsW Brinjikji, S A Cofer, J I Lane
JournalAJNR. American journal of neuroradiology (AJNR Am J Neuroradiol) Vol. 36 Issue 6 Pg. 1182-7 (Jun 2015) ISSN: 1936-959X [Electronic] United States
PMID25678484 (Publication Type: Journal Article)
Copyright© 2015 by American Journal of Neuroradiology.
Chemical References
  • Dextrans
  • dextranomer-hyaluronic acid copolymer
  • Hyaluronic Acid
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Dextrans (administration & dosage)
  • Diagnostic Errors
  • Female
  • Humans
  • Hyaluronic Acid (administration & dosage)
  • Injections
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Postoperative Complications (diagnosis)
  • Prostheses and Implants
  • Retropharyngeal Abscess (diagnosis)
  • Tomography, X-Ray Computed
  • Velopharyngeal Insufficiency (diagnosis, surgery)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: